Dianabol 10mg

Vanguard Labs Methandrostenolone (Dianabol 10mg) is a fast-acting oral compound formulated for users seeking rapid strength increases, enhanced training output, and noticeable gains in size over short timeframes. Produced to the standards expected of Vanguard Labs, this Dianabol offering reflects a commitment to dosing accuracy, consistency, and harm-reduction awareness. Within the VGL Fitness range, Dianabol 10mg is best suited to mass-focused phases or short kick-start periods where performance and workload capacity are the priority. Trusted by users of VGL Fitness products for its predictable profile, Vanguard Labs Dianabol supports fuller muscles, increased glycogen storage, and improved training intensity, with results that are both rapid and measurable when used responsibly.

Methandrostenolone (Dianabol 10mg) – Harm Reduction Crib Sheet

Compound: Methandrostenolone (Dianabol, Dbol)
Class: Oral Anabolic-Androgenic Steroid (AAS), Derivative of Testosterone
Administration: Oral

Dosage

• Performance Use: 20–40 mg/day
• Advanced Use: Advanced users may push higher, but risk escalates rapidly
• Cycle Length: 4–6 weeks (Absolute Max)

Half-Life

• ~4 to 6 hours

Dosing Frequency: 2–3 times daily to maintain more stable blood levels

Benefits

• Rapid increases in strength and scale weight
• Significant glycogen and intracellular water retention (fuller look)
• Enhanced training performance and recovery
• Strong anabolic effect over short timeframes
• Psychological “drive” and aggression in training (individual dependent)

Side Effects)

• Oestrogenic: Water retention, bloating, gynecomastia
• Hepatotoxicity: Moderate to high (17α-alkylated oral)
• Androgenic: Acne, oily skin, hair loss (dose and genetics dependent)
• Suppression: Strong inhibition of natural testosterone production
• Blood Pressure: Can increase due to water retention
• Appetite changes: Often increases markedly

Risks

• Liver Strain: Elevated ALT/AST common, especially beyond 4–6 weeks
• Cardiovascular: Significant HDL suppression, LDL elevation
• Endocrine: Full HPTA suppression in men
• Oestrogen Management: Increased risk of gyno without mitigation
• Psychological: Irritability, mood swings possible at higher doses

Risk Mitigation

• Bloodwork: Liver enzymes, lipids, TT/FT, CBC pre- and post-cycle (mid-cycle advised)
• Cycle Support: NAC 600–1200 mg/day, TUDCA strongly advised (250–500 mg/day)
• Oestrogen Control: AI may be required depending on dose and individual response, Do not over-suppress
• Blood Pressure Management:: Cardio, electrolytes, hydration, sodium awareness
• Testosterone Base: Strongly recommended to maintain function and reduce crash post-cycle
• Avoid Alcohol: Non-negotiable during use
• Limit Duration:: Short cycles only. Longer use = disproportionate risk

Post-Cycle Therapy (PCT)

If not transitioning to TRT

• Start: 3–5 days after last Dianabol dose
• Tamoxifen (Nolvadex):
  • 40 mg/day (Weeks 1–2) → 2 x 20mg caps daily
  • 20 mg/day (Weeks 3–4) → 1 x 20mg cap daily
• Optional – Clomiphene (Clomid): 50 mg/day for 4 weeks → 1 x 50mg cap daily
• Follow-up labs: 4–6 weeks post-PCT to assess recovery